| Myasthenia gravis: treatment with plasma exchange experiences over 10 years. | |
| | |
MedLine Citation:
|
PMID: 1822852 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Evaluation of the results of plasmapheresis therapy is reviewed on 160 patients suffering from myasthenia gravis. This new therapeutical procedure is considered very valuable: improvement can be achieved in 63% of the patients during the therapy, a further improvement in 30% after it. Plasmapheresis is especially effective for patients in respiratory crisis-prone state, for drug-resistant cases and for preparation patients for surgery. Plasma exchange therapy may be combined with other forms of immunosuppression with benefit. Thymectomy and plasma exchange are considered to be the main therapeutical procedures in myasthenia gravis. |
| | |
Authors:
|
L Fornádi; R Horváth; A Szobor |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Acta medica Hungarica Volume: 48 ISSN: 0236-5286 ISO Abbreviation: Acta Med Hung Publication Date: 1991 |
Date Detail:
|
Created Date: 1992-09-08 Completed Date: 1992-09-08 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8400269 Medline TA: Acta Med Hung Country: HUNGARY |
Other Details:
|
Languages: eng Pagination: 137-44 Citation Subset: IM |
Affiliation:
|
Dept. of Neurology, Ferenc Jahn Teaching Hospital, Budapest. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Follow-Up Studies Humans Immunosuppression Myasthenia Gravis / therapy* Plasmapheresis* Retrospective Studies Treatment Outcome |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Parkinson's syndrome: cranial computed-tomography findings. Their dependence on sex and age.
Next Document: Prenatal cytogenetic study of translocation carriers.